- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Male Breast Carcinoma in Russian Federation
Total 956 results
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, India, Korea, Republic of, Taiwan, Spain, Germany, Austria, Italy, Peru, Russian Federation, Singapore, France, United Kingdom, Philippines, Argentina
-
BayerActive, not recruitingProstate CancerUnited States, Canada, Japan, Spain, Germany, Belgium, Argentina, Austria, Brazil, Greece, Italy, Russian Federation, Taiwan, China, Denmark, France, Colombia
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Active Biotech ABCompletedRenal Cell CarcinomaRomania, Russian Federation, United Kingdom, Ukraine, Bulgaria
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Hoffmann-La RocheCompletedBreast CancerSpain, United States, France, Germany, Belgium, Korea, Republic of, Italy, Russian Federation
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaSpain, Canada, Portugal, Korea, Republic of, Taiwan, United States, Netherlands, United Kingdom, Czechia, Italy, Finland, Greece, Romania, Australia, Poland, Russian Federation
-
AstraZenecaHutchinson MediPharma (HMP)Active, not recruitingKidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Neoplasms by Site | Kidney Diseases | Carcinoma | Enzyme Inhibitors | Protein Kinase InhibitorsUnited States, Italy, France, Korea, Republic of, Brazil, Russian Federation, Ukraine
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
IpsenTerminatedCarcinoid SyndromeSpain, Belgium, Ireland, Czechia, Israel, France, United Kingdom, Latvia, Germany, Russian Federation, Slovakia, Italy, Netherlands, Finland, Austria, Poland, Sweden, Ukraine
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingRenal Cell CarcinomaFrance, Spain, Chile, United States, Argentina, Austria, Czechia, Greece, Italy, Mexico, Poland, Portugal, Romania, Russian Federation
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
European Organisation for Research and Treatment...CompletedKidney CancerSwitzerland, Netherlands, Norway, Belgium, United Kingdom, Hungary, Italy, Turkey, Russian Federation
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
SanofiCompletedProstatic NeoplasmsUnited States, France, Brazil, Russian Federation, Australia, Turkey, India, Austria, Israel, Italy, Mexico, United Kingdom, Germany, Poland, Netherlands, South Africa, Canada
-
IpsenCompletedCarcinoid SyndromeUnited States, Turkey, Brazil, India, Ukraine, South Africa, Czechia, Latvia, Poland, Russian Federation, Serbia
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
BiocadRecruitingNon-Squamous Non-Small Cell Neoplasm of LungCzechia, Romania, Georgia, Hungary, Russian Federation, Slovakia
-
SandozSandoz GmbHCompletedBreast Cancer | Chemotherapy-induced NeutropeniaSpain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
-
AO GENERIUMCompletedParoxysmal Nocturnal HemoglobinuriaRussian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
BayerCompletedLiver NeoplasmsUnited States, Canada, Japan, Spain, Sweden, Belgium, Argentina, Austria, Greece, Italy, Korea, Republic of, Netherlands, Russian Federation, Taiwan, Turkey, China, Denmark, Egypt, France, Saudi Arabia, Thailand
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Hoffmann-La RocheCompletedBreast CancerItaly, Korea, Republic of, Spain, Taiwan, United Kingdom, Brazil, Russian Federation, Thailand, Israel, Turkey, Austria, Canada, Poland, Sweden, Australia, Peru, Switzerland, Mexico
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerFrance, Poland, Taiwan, Spain, Israel, Belgium, Russian Federation, Czech Republic, Hungary, Australia
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
HI-BioCompletedGlomerulonephritis | Membranous Nephropathy | antiPLA2R PositiveTaiwan, Korea, Republic of, Greece, Germany, United Kingdom, Georgia, Russian Federation
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingRenal Cell Carcinoma (RCC)Canada, France, United States, Spain, United Kingdom, Italy, Taiwan, Australia, Norway, Korea, Republic of, Germany, Russian Federation, Japan, Brazil, Turkey, Ukraine, Hungary, New Zealand, Chile, Ireland
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
AstraZenecaRecruitingPapillary Renal Cell CarcinomaChina, Czechia, Israel, Netherlands, Spain, United Kingdom, Korea, Republic of, Italy, India, Mexico, Turkey, Argentina, Australia, Canada, Germany, Russian Federation, Taiwan, United States, Poland, Brazil, Chile, Hong Kong, Ukraine, Franc... and more
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
SanofiCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Neoplasm Recurrence, LocalRussian Federation, United States, Canada, Germany, Hungary, Italy, South Africa, Argentina, Uruguay, Austria, Switzerland, Israel, Belgium, France, Australia, Brazil, Greece, Guadeloupe, Réunion, Spain
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
PfizerRecruitingSmall Cell Lung Cancer (SCLC) | Follicular Lymphoma (FL) | Castration Resistant Prostate Cancer (CRPC)United States, Spain, Korea, Republic of, Poland, China, Bulgaria, Russian Federation, Japan
-
Ionis Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States, Hungary, Poland, Russian Federation
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
Hoffmann-La RocheCompletedRenal Cell CancerGermany, Estonia, Russian Federation, Italy, United Kingdom, Netherlands, Greece, Switzerland, Finland, Lithuania, Sweden, Czech Republic